Scr was measured using an automated assay on the Cobas 8000 C702 system (Roche Diagnostics, Basel, Switzerland).
Cobas 8000 c702 system
Manufactured by Roche
Sourced in Switzerland
The Cobas 8000 C702 system is a modular, automated clinical chemistry analyzer designed for high-volume clinical laboratory testing. It is capable of performing a variety of routine and specialized assays, including tests for chemistry, immunochemistry, and therapeutic drug monitoring. The Cobas 8000 C702 system is designed to provide efficient and reliable results to support clinical decision-making.
Automatically generated - may contain errors
Lab products found in correlation
3 protocols using cobas 8000 c702 system
1
Automated Scr Assay on Cobas 8000
2
SARS-CoV-2 Antibodies and Inflammation in Mother-Child Dyads
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Venous blood was collected from both the children and mothers in EDTA-coated plain and heparinized vacutainer tubes, and transported at 2–8°C to the National Institute for Medical Research (NIMR) Korogwe Research Laboratory for further processing and laboratory analyses. Plasma was separated within 2 hours of collection in a refrigerated centrifuge. All samples were stored at −80°C and later shipped on dry ice to Rigshospitalet, Denmark for the detection of anti-SARS-CoV-2 antibodies by ELISA. High-sensitivity C-reactive protein (hs-CRP) was measured in the Department of Clinical Biochemistry, Copenhagen University Hospital, using the Cobas 8000 c702 system (Roche Diagnostics).
At the study site, point-of-care diagnostics were performed on the venous blood including the estimation of haemoglobin (Hb) (Sysmex KX-21N), fasting blood glucose (HemoCue 301), and malaria rapid diagnostic test (mRDT) (ParaHIT or CareStart Malaria Pf). For participants with a positive mRDT, the parasitaemia was confirmed by two independent expert microscopists. HIV infection was tested with the Determine HIV-1/2 test kit (Alere Ltd) and seropositive cases were confirmed using the Unigold test kit (Trinity Biotech Plc). All tests were done according to the manufacturer's instructions.
At the study site, point-of-care diagnostics were performed on the venous blood including the estimation of haemoglobin (Hb) (Sysmex KX-21N), fasting blood glucose (HemoCue 301), and malaria rapid diagnostic test (mRDT) (ParaHIT or CareStart Malaria Pf). For participants with a positive mRDT, the parasitaemia was confirmed by two independent expert microscopists. HIV infection was tested with the Determine HIV-1/2 test kit (Alere Ltd) and seropositive cases were confirmed using the Unigold test kit (Trinity Biotech Plc). All tests were done according to the manufacturer's instructions.
3
Comprehensive Metabolic Panel Analysis
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Urea and glucose concentrations were measured by kinetic colorimetric assays using the UREAL (Roche Diagnostics, Cat.# 05171873 190) and GLUC3 kit (Roche Diagnostics, Cat.# 05168791 190). Cholesterol, TRIGLycerides and lipoprotein concentrations were measured via enzymatic color assays using the CHOL2 (Roche Diagnostics, Cat.# 05168538 190), TRIGL (Roche Diagnostics, Cat.# 05171407 190), HDLC4 kit (Roche Diagnostics, Cat.# 07528582 190) and LDLC3 kit (Roche Diagnostics, Cat.# 07005768 190). These analyses were performed on a Cobas 8000/c702 system (Roche Diagnostics) according to the instructions of the manufacturer. Cortisol, Insulin and c-peptide concentrations were measured via electrochemiluminescence immunoassays (ECLIA) using the Cortisol II (Roche Diagnostics, Cat.# 07027150 190), Insulin (Roche Diagnostics, Cat.# 07027559 190) and C-Peptide kit (Roche Diagnostics, Cat.# 07027168 190) on a Cobas 8000/e801 system (Roche Diagnostics) according to the instructions of the manufacturer.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!